2. Signaling Pathways
  3. JAK/STAT Signaling
    Protein Tyrosine Kinase/RTK
  4. EGFR
  5. ErbB2/HER2 Isoform
  6. ErbB2/HER2 Antagonist

ErbB2/HER2 Antagonist

ErbB2/HER2 Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P991588
    HLX-22
    		Antagonist 99.47%
    HLX-22 is a humanized monoclonal antibody targeting HER2. HLX-22 induces apoptosis in HER2-overexpressing breast and gastric cancer cells combined with Trastuzumab (HY-P9907). HLX-22 has potent antitumor activity against advanced solid tumors.